Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
BOSTON — Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two posters at the Canadian Society of Allergy and Clinical
(Financial Post, 2025-10-09T12:06:14Z)